A practical reference on tesamorelin: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-09 and is reviewed periodically as new material appears.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
=== Plant source === Generally, honey is classified by the floral source of the nectar from which it was made. Honeys can be from specific types of flower nectars or can be blended after collection. The pollen in honey is traceable to floral source and therefore region of origin. The rheological and melissopalynological properties of honey can be used to identify the major plant nectar source used in its production.
Before drying to make copra, raw coconut meat is 47% water, 33% fat, 15% carbohydrates, and 3% protein (table). In a reference amount of 100 grams (3.5 oz), raw coconut flesh supplies 354 calories of food energy, and is a rich source (20% or more of the Daily Value, DV) of manganese (65% DV), with various other dietary minerals in moderate amounts (10–18% DV; table). It is a poor source of vitamins. Raw coconut meat has a high content of saturated fatty acids (89% of total fats), with lauric acid as the main saturated fat (15% of total; USDA source in table).
In peritoneal dialysis, a sterile solution containing glucose (called dialysate) is run through a tube into the peritoneal cavity, the abdominal body cavity around the intestine, where the peritoneal membrane acts as a partially permeable membrane. This exchange is repeated 4–5 times per day; automatic systems can run more frequent exchange cycles overnight. Peritoneal dialysis is less efficient than hemodialysis, but because it is carried out for a longer period of time the net effect in terms of removal of waste products and of salt and water are similar to hemodialysis. Peritoneal dialysis is carried out at home by the patient, often without help. This frees patients from the routine of having to go to a dialysis clinic on a fixed schedule multiple times per week. Peritoneal dialysis can be performed with little to no specialized equipment (other than bags of fresh dialysate).
=== By children in Gaza === In November 2023, a group of children outside al-Shifa Hospital held a press conference asking the world for an end to the war. A small group of children in Rafah held their own protest in advance of a planned Rafah offensive in February 2024, holding signs in English that read "We refuse to die" and "Save us from this genocide". Children in Rafah again held their own protest against the Gaza Strip famine on 6 March, holding a banner reading "Stop our daily death". In February 2024, a boy wounded in an Israeli attack stated, "I don’t know why they attacked me. They are picking fights against the children of Palestine. Why?" In July 2024, a 10th grade student in Ramallah said hearing explosions on the news "just twisted something inside of me, like I felt those emotions coming out. I was scared. I was terrified, actually. It could be me next."
Sources: en.wikipedia.org
The Cave of the High Place in the Small Valley (Cave 181), also called the "Highest Cave", is described extensively by Albert Grünwedel, as a particularly interesting cave of the small ravine. He explains that the cave is located high up on the right side of the ravine, which accounts for the fact that its murals have been preserved from the usual iconoclastic vandalism: the faces in particular are well preserved. Also, the murals did not use gold foils for decoration, which reduced the incentive for theft. In his plates, Grünwedel illustrates the murals of the cave, where he names the cave by its official name: Hochliegende Höhle der 2. Schlucht ("Cave of the High Place in the 2nd Valley"), which is the German name for cave 181. Grünwedel explains that the structure of the cave is extremely rare, as it is not a barrel-vaulted cave: instead, the ceiling has the shape of a tent. The flatness of the sides of the tent-like ceiling is the reason why Grünwedel was able to remove easily most of the ceiling paintings in large panels, something which is impossible with the strongly curved surface of a barrel-vaulted ceiling. The tent-like ceiling is bordered by a row of seven bejewelled princes on each side. The side wall depict rather tumultuous scenes of the sermon of the Buddha, no fewer than eight of them, with a multitude of attendants in various attitudes and clothing. The entrance wall had paintings of Tocharian donors and monks on both side. Above the entrance was the usual painting of Maitreya with surrounding Devaputras.
== Appearances == Half-Life opens on Gordon Freeman as a research assistant at the Anomalous Materials wing of the Black Mesa Research Facility. After donning the Hazardous Environment suit for an experiment, Freeman survives an interdimensional "resonance cascade", taking up a crowbar as his signature weapon and fighting his way across the facility against both extradimensional invaders and hostile US marines to seal the rift. In Half-Life 2, after being kept in stasis for nearly two decades, Freeman battles the Combine Empire to liberate Earth. He gains legendary status as part of the resistance against the Combine forces and sparks a rebellion, ultimately destroying the Citadel, a major Combine stronghold. The G-Man rescues Freeman after this critical event, praising his accomplishments and placing him back in stasis. In Episode One, Gordon Freeman and Alyx Vance work to stabilize the Citadel's core to prevent a catastrophic explosion. In Episode Two, they work together to transport crucial data to close a forming super portal. After a revelation from the G-Man about saving Alyx, they learn about the Borealis, a research vessel with the potential to cause significant events. The game ends with Alyx mourning her father's death at the hands of a Combine Advisor. Half-Life: Alyx, set five years before Half-Life 2, follows Alyx Vance trying to locate Gordon. She infiltrates a Combine vault, believing it holds Gordon, but instead releases the G-Man.
== Enabling technologies == Several novel enabling technologies were critical to the success of synthetic biology. Concepts include standardization of biological parts and hierarchical abstraction to permit using those parts in synthetic systems. DNA serves as the guide for how biological processes function. The ability to comprehend and design biological systems has undergone significant modifications as a result of developments in the previous few decades in both reading (sequencing) and writing (synthesis) DNA sequences. These developments have produced ground-breaking techniques for designing, assembling, and modifying DNA-encoded genes, materials, circuits, and metabolic pathways, enabling an ever-increasing amount of control over biological systems and even entire organisms. Basic technologies include reading and writing DNA (sequencing and fabrication). Measurements under multiple conditions are needed for accurate modeling and computer-aided design (CAD).
Michael Balint (Hungarian: Bálint Mihály; 3 December 1896 – 31 December 1970) Hungarian Jewish psychoanalyst convert to Christianity who spent most of his adult life in England. He was a proponent of the Object Relations school and author of numerous academic texts and monographs on psychiatry; was attached to the Tavistock Clinic; in 1968 Balint became president of the British Psychoanalytical Society; his wife was noted psychoanalyst and author, Enid Balint, who directed British Psychoanalytical Society (now Institute of Psychoanalysis). A volume of her papers, Before I was I: Psychoanalysis and the Imagination, was published in 1993. Simon Baron-Cohen (b.1958); clinical psychologist ; professor of developmental psychopathology at University of Cambridge; director of the university's Autism Research Centre and a Fellow of Trinity College; was knighted for services to people with autism; was awarded the Medical Research Council (MRC) Millennium Medal; He is the 2026 recipient of the Grawemeyer Award in Psychology. brother of Sacha Baron Cohen Zygmunt Bauman (19 November 1925 – 9 January 2017) highly influential Polish Jewish writer, sociologist and philosopher, writing on postmodern consumerism and liquid modernity.
=== Aesthetic medicine === Platelet-rich plasma therapy is a minimally invasive procedure that may be used in aesthetic medicine to treat skin conditions such as the removal of wrinkles, the reduction of lines, and improvement of blemishes, and hair loss. Concentrated PRP solution is injected into the treatment area to target damaged cells and tissues. The growth factors and proteins in PRP aid in rejuvenating the skin, and improving the condition of the scalp stimulating hair growth.
Sources: en.wikipedia.org
Clostridium botulinum Clostridium perfringens Bacillus cereus The rare but potentially deadly disease botulism occurs when the anaerobic bacterium Clostridium botulinum grows in improperly canned low-acid foods and produces botulin, a powerful paralytic toxin. Pseudoalteromonas tetraodonis, certain species of Pseudomonas and Vibrio, and some other bacteria, produce the lethal tetrodotoxin, which is present in the tissues of some living animal species rather than being a product of decomposition.
Prolific in film since 1964, Freeman is known for his roles in genres ranging from dramas, historical epics, thrillers, action adventure, science fiction, and comedies. His most acclaimed and highest-grossing films, according to the review aggregate site Rotten Tomatoes, include the following:
=== Latest history === In April 2022, the business announced it would acquire Sierra Oncology Inc. for $1.9 billion ($55 per share). In May 2022, GSK announced it would acquire Affinivax and its phase II 24-valent pneumococcal vaccine candidate for up to $3.3 billion, strengthening its vaccine business. On 16 May 2022, the company changed its name from GlaxoSmithKline to GSK. In April 2023, GSK announced it would acquire Bellus Health Inc. for $2 billion. In February 2024, the company acquired Aiolos Bio for over $1 billion, adding to its existing asthma business through AIO-001, a long-acting monoclonal antibody that targets the thymic stromal lymphopoietin cytokine. In May 2024, GSK sold off its 4.2% shareholding in Haleon for $1.58 billion. In July 2024, GSK moved its headquarters from Brentford to New Oxford Street in central London. As of 2025, capital investments in the company via its American Depository Receipts in New York were outpacing those via the company's primary listing in London. Mounting speculation that GSK would be moving its primary share listing to the New York Stock Exchange, following similar speculation about rival AstraZeneca, has been met with denials from GSK's corporate executives. In September 2025, the company announced Emma Walmsley was stepping down as chief executive at the beginning of 2026. GSK has appointed Luke Miels as her replacement, who has been the company's chief commercial officer since 2017.
=== Parkinson's disease === Barran has been working with Joy Milne to search for odorous biomarkers of Parkinson's disease. By smelling skin swabs, Milne says she can differentiate between people with and without Parkinson's disease. She says she identified changes in her husband's scent before he was formally diagnosed with Parkinson's disease, which he died of in 2015. Barran uses mass spectrometry to investigate the biomarkers of Parkinson's disease. The story was made into a BBC documentary The Woman Who Can Smell Parkinson's. Barran received ethical approval for her work of the skin metabolites of Parkinson's in 2015, allowing them to work with Parkinson's UK to conduct a larger study. In 2018 Milne travelled to the Tanzanian training centre APOPO to check whether she could smell Tuberculosis. Barran's work on Parkinson's is sponsored by The Michael J. Fox Foundation. In 2022, Barran and others published a study of a method to detect Parkinson's disease by analysing sebum using mass spectrometry.
Pinoline, also known as 6-methoxytryptoline or as 6-methoxy-1,2,3,4-tetrahydro-β-carboline (6-MeO-THβC), is a β-carboline long-claimed to be produced in the pineal gland during the metabolism of melatonin, however its pineal occurrence remains controversial. Its more common name is a contraction of "pineal β-carboline". The biological activity of this molecule is of interest as a potential free radical scavenger, also known as an antioxidant, and as a monoamine oxidase A inhibitor.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.